In the final quarter of 2025, U.S. equity markets experienced robust growth, extending a three-year streak of double-digit returns. This period was characterized by large-cap equities showing a modest lead over small-cap firms, both of which outpaced mid-capitalization companies. Notably, Alphatec's advancements in spine surgery technology and imaging solutions were significant contributors to its revenue and profit expansion. The investment strategy involved a reduction in healthcare sector holdings and an increased allocation to information technology, particularly within the semiconductor industry, reflecting a dynamic approach to market opportunities.
The fourth quarter of 2025 underscored a resilient U.S. stock market. Despite a brief government shutdown in October extending into November, investor confidence remained largely unshaken. This period saw a continuation of strong performance across various market segments, with particular strength observed in large-cap stocks. The performance indicators suggested a healthy economic environment, allowing equities to flourish for yet another year. This consistent growth highlighted the market's ability to absorb minor political disruptions without significant long-term impact on investor sentiment or market trajectory.
A notable aspect of the quarter's performance was the strong showing of Alphatec. The company reported impressive revenue and profit growth, primarily driven by the accelerated adoption of its innovative spine surgery technology and advanced imaging platform by medical professionals. This success story exemplifies how technological innovation in the healthcare sector can translate into significant financial gains, contributing positively to overall market performance and investor confidence in specialized segments.
Strategic portfolio rebalancing played a crucial role in navigating the market dynamics of Q4 2025. American Century Investments made deliberate moves, shifting its position in the healthcare sector from overweight to underweight. This adjustment involved divesting from certain portfolio companies within healthcare. Conversely, the information technology sector, initially underweight, was reclassified as overweight following the introduction of several new investment opportunities in the semiconductor and semiconductor equipment manufacturing industries. These adjustments were aimed at optimizing the portfolio's alignment with emerging market trends and growth potential.
The concluding quarter of 2025 showcased a dynamic investment landscape where U.S. stock markets continued their impressive upward trend. While large-cap stocks demonstrated slight superiority, the overall market strength was undeniable. Key to this quarter's narrative were significant earnings from companies like Alphatec, alongside strategic sector reallocations designed to capitalize on evolving economic conditions. These moves underscored a proactive investment philosophy, adapting to market signals for sustained growth and risk management.
